R1	Has_value Arg1:T1 Arg2:T2	
R2	Has_negation Arg1:T11 Arg2:T10	
R3	Has_negation Arg1:T13 Arg2:T8	
R4	Has_temporal Arg1:T13 Arg2:T14	
R5	AND Arg1:T9 Arg2:T13	
R6	Has_multiplier Arg1:T7 Arg2:T6	
R7	Has_temporal Arg1:T12 Arg2:T11	
*	OR T7 T12 T13
R8	Has_value Arg1:T5 Arg2:T15	
R9	Has_value Arg1:T16 Arg2:T17	
R10	Has_value Arg1:T18 Arg2:T19	
R11	Has_negation Arg1:T23 Arg2:T22	
R12	AND Arg1:T23 Arg2:T25	
R13	Has_negation Arg1:T28 Arg2:T26	
R14	Has_temporal Arg1:T28 Arg2:T27	
R15	Has_value Arg1:T29 Arg2:T30	
R16	Has_value Arg1:T31 Arg2:T32	
R17	Has_value Arg1:T33 Arg2:T34	
R18	Has_value Arg1:T37 Arg2:T39	
R19	Has_value Arg1:T38 Arg2:T40	
R20	Has_value Arg1:T41 Arg2:T42	
R21	Has_negation Arg1:T57 Arg2:T53	
R22	Has_negation Arg1:T58 Arg2:T54	
R23	Has_temporal Arg1:T57 Arg2:T55	
R24	Has_temporal Arg1:T58 Arg2:T56	
R25	Has_negation Arg1:T47 Arg2:T45	
R26	AND Arg1:T47 Arg2:T51	
R27	Has_temporal Arg1:T47 Arg2:T49	
R28	Has_temporal Arg1:T23 Arg2:T24	
R29	Has_negation Arg1:T48 Arg2:T46	
R30	AND Arg1:T48 Arg2:T52	
R31	Has_temporal Arg1:T48 Arg2:T50	
R32	Has_value Arg1:T59 Arg2:T60	
R33	Has_value Arg1:T61 Arg2:T62	
R34	Has_value Arg1:T64 Arg2:T63	
R35	Has_value Arg1:T65 Arg2:T66	
T1	Person 0 4	aged
T2	Value 5 15	= 6 months
T3	Informed_consent 17 47	sign the informed consent form
T4	Post-eligibility 49 160	the legal guardians participate in all the planned follow-up and be able to comply with all research procedures
T6	Multiplier 216 217	2
T7	Drug 218 256	needle recombinant hepatitis B vaccine
T8	Negation 267 269	no
T9	Drug 293 305	EV71 vaccine
T10	Negation 311 313	no
T11	Temporal 314 321	history
T12	Condition 325 339	EV71 infection
T13	Procedure 270 281	inoculation
T14	Temporal 282 289	history
T5	Observation 345 371	last vaccination intervals
T15	Value 372 381	= 14 days
T16	Measurement 383 394	temperature
T17	Value 395 407	= 37<U+2103>
T18	Person 409 413	aged
T19	Value 414 424	= 6 months
T20	Informed_consent 426 456	sign the informed consent form
T21	Post-eligibility 458 569	the legal guardians participate in all the planned follow-up and be able to comply with all research procedures
T22	Negation 580 582	no
T23	Procedure 583 594	inoculation
T24	Temporal 595 602	history
T25	Drug 606 618	EV71 vaccine
T26	Negation 633 635	no
T27	Temporal 636 643	history
T28	Condition 647 661	EV71 infection
T29	Observation 667 693	last vaccination intervals
T30	Value 694 703	= 14 days
T31	Measurement 705 716	temperature
T32	Value 717 729	= 37<U+2103>
T33	Person 731 735	aged
T34	Value 736 746	= 8 months
T35	Informed_consent 748 778	sign the informed consent form
T36	Informed_consent 1124 1154	sign the informed consent form
T37	Measurement 1081 1092	temperature
T38	Measurement 1460 1471	temperature
T39	Value 1093 1105	= 37<U+2103>
T40	Value 1472 1484	= 37<U+2103>
T41	Person 1107 1111	aged
T42	Value 1112 1122	= 8 months
T43	Post-eligibility 780 891	the legal guardians participate in all the planned follow-up and be able to comply with all research procedures
T44	Post-eligibility 1156 1267	the legal guardians participate in all the planned follow-up and be able to comply with all research procedures
T45	Negation 902 904	no
T46	Negation 1278 1280	no
T47	Procedure 905 916	inoculation
T48	Procedure 1281 1292	inoculation
T49	Temporal 917 924	history
T50	Temporal 1293 1300	history
T51	Drug 928 940	EV71 vaccine
T52	Drug 1304 1316	EV71 vaccine
T53	Negation 955 957	no
T54	Negation 1331 1333	no
T55	Temporal 958 965	history
T56	Temporal 1334 1341	history
T57	Condition 969 983	EV71 infection
T58	Condition 1345 1359	EV71 infection
T59	Observation 989 1015	last vaccination intervals
T60	Value 1016 1025	= 14 days
T61	Observation 1034 1072	last attenuated live vaccine intervals
T62	Value 1072 1079	=28days
T63	Value 1449 1458	= 28 days
T64	Observation 1410 1448	last attenuated live vaccine intervals
T65	Observation 1365 1391	last vaccination intervals
T66	Value 1392 1401	= 14 days
